A new method of contraception that men can use has just passed a major test and is on its way to becoming a viable commercial birth-control method. It involves the injection of a substance that can control the amount of sperm that males can produce. This provides men with a permanent solution that beats what wearing a condom or undergoing vasectomy can offer. What’s more, it’s entirely reversible.
Right now, men only have a few options with regards to contraception, Futurism notes. Either they wear condoms or get a vasectomy. Of course, there’s always the option of abstinence, but that’s not really a viable solution for most males. This is why Vasalgel is such a huge deal because it involves a single injection that can remove a substantial amount of pressure that people feel every day.
The threat of pregnancy can have a severe impact on several aspects of people’s lives. Studies have shown how societies with limited options in birth control are more likely to experience poverty, shorter life-spans, and an increased vulnerability to diseases. There’s also the matter of crippling anxiety and depression that often accompanies unexpected or unintended pregnancies, which teens represent a considerable percentage of.
So, how does Valagel work? According to the Parsemus Foundation’s website where the contraceptive’s page is hosted, it’s basically like putting a filter in the tube where sperms swim through in order to limit how much of the little tadpoles can get past.
“The procedure is similar to a no-scalpel vasectomy, except a gel is injected into the vas deferens (the tube the sperm swim through), rather than cutting the vas (as is done in vasectomy),” the site’s description reads. “If a man wishes to restore flow of sperm, whether after months or years, the polymer is flushed out of the vas with another injection.”


SpaceX Starship Explodes in Texas During Test, Citing Nitrogen Tank Failure
Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay
CDC Vaccine Review Sparks Controversy Over Thimerosal Study Citation
Kennedy Sets September Deadline to Uncover Autism Causes Amid Controversy
Tabletop particle accelerator could transform medicine and materials science
Lab-grown meat: you may find it icky, but it could drive forward medical research
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
Neuralink Expands Brain Implant Trials with 12 Global Patients
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission 



